US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist

0.724
+0.017+2.46%

Close Sep 27 16:00 ET

0.724
0.0000.00%

Post 20:02 ET

90.26MMarket Cap-635P/E (TTM)

Karyopharm Therapeutics Stock Forum

QMengColdJoke

Aug 29 15:40

Yeah CFO is gone, just hire someone on street!

$Karyopharm Therapeutics (KPTI.US)$ This dude was hired when stock price was 10 dollar. Now we are screwed. looks like a let resign. He’s good controller but probably a really bad CFO.

QMengColdJoke

Aug 6 15:18

Board should fire most employees

$Karyopharm Therapeutics (KPTI.US)$ so we would be back in profit, cash flow for the medicine would make shares back to 8 to 10 zone. No idea what’s the plan. Keep bleeding to death?

carlton griffiths

Jul 11 12:53

$Karyopharm Therapeutics (KPTI.US)$

carlton griffiths

Jul 9 17:19

$Karyopharm Therapeutics (KPTI.US)$ maby bot

Trytosaveabit

Jul 3 13:45

Again why????

$Karyopharm Therapeutics (KPTI.US)$ Compare pictures and MM is not showing correct PA on chart????

carlton griffiths

Jun 26 07:35

$Karyopharm Therapeutics (KPTI.US)$ lights 👀

Jaguar8

Jun 1 12:46

NEWS

$Karyopharm Therapeutics (KPTI.US)$
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates
Karyopharm Therapeutics presented updated subgroup analyses from the SIENDO study at the 2024 ASCO Meeting, focusing on advanced or recurrent TP53 wild-type endometrial cancer. Key findings include a median progression-free survival (PFS) of 28.4 months fo...